X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2847) 2847
drug combinations (2825) 2825
male (2204) 2204
oxonic acid - administration & dosage (1966) 1966
tegafur - administration & dosage (1955) 1955
aged (1843) 1843
female (1766) 1766
middle aged (1723) 1723
antineoplastic combined chemotherapy protocols - therapeutic use (1675) 1675
stomach neoplasms - drug therapy (1265) 1265
oxonic acid - therapeutic use (1139) 1139
tegafur - therapeutic use (1136) 1136
oncology (1045) 1045
index medicus (1021) 1021
stomach neoplasms - pathology (992) 992
adult (952) 952
s-1 (892) 892
chemotherapy (756) 756
cisplatin - administration & dosage (745) 745
treatment outcome (673) 673
cancer (649) 649
oxonic acid - adverse effects (624) 624
tegafur - adverse effects (616) 616
antimetabolites, antineoplastic - therapeutic use (602) 602
drug administration schedule (601) 601
stomach neoplasms - surgery (586) 586
neoplasm staging (576) 576
antimetabolites, antineoplastic - administration & dosage (499) 499
aged, 80 and over (479) 479
antineoplastic combined chemotherapy protocols - adverse effects (467) 467
5-fluorouracil (463) 463
adenocarcinoma - drug therapy (431) 431
combined modality therapy (415) 415
gastrectomy (411) 411
pyridines - administration & dosage (387) 387
medicine & public health (382) 382
administration, oral (381) 381
cisplatin (376) 376
gastric cancer (357) 357
survival rate (355) 355
deoxycytidine - analogs & derivatives (350) 350
lymphatic metastasis (339) 339
fluorouracil (328) 328
chemotherapy, adjuvant (322) 322
liver neoplasms - secondary (318) 318
animals (316) 316
tomography, x-ray computed (315) 315
disease-free survival (313) 313
stomach cancer (310) 310
pharmacology & pharmacy (299) 299
camptothecin - analogs & derivatives (295) 295
trial (287) 287
care and treatment (286) 286
antineoplastic combined chemotherapy protocols - administration & dosage (267) 267
liver neoplasms - drug therapy (262) 262
prognosis (255) 255
surgery (255) 255
carcinoma (253) 253
camptothecin - administration & dosage (251) 251
retrospective studies (250) 250
cancer research (246) 246
deoxycytidine - administration & dosage (242) 242
antimetabolites, antineoplastic - adverse effects (237) 237
taxoids - administration & dosage (232) 232
lung neoplasms - drug therapy (231) 231
neoadjuvant therapy (231) 231
fluorouracil - administration & dosage (226) 226
therapy (223) 223
pancreatic neoplasms - drug therapy (221) 221
paclitaxel - administration & dosage (217) 217
research (215) 215
stomach neoplasms - mortality (209) 209
surgical oncology (206) 206
capecitabine (199) 199
phase-ii (197) 197
antineoplastic agents (196) 196
remission induction (196) 196
adenocarcinoma - pathology (195) 195
survival (194) 194
antimitotic agents (192) 192
peritoneal neoplasms - secondary (192) 192
time factors (192) 192
metastasis (184) 184
adenocarcinoma - secondary (182) 182
radiotherapy (182) 182
pancreatic neoplasms - pathology (181) 181
organoplatinum compounds - administration & dosage (177) 177
clinical trials (175) 175
follow-up studies (175) 175
oxaliplatin (175) 175
analysis (171) 171
dose-response relationship, drug (169) 169
adjuvant chemotherapy (168) 168
rats (168) 168
mice (164) 164
pyridines - therapeutic use (163) 163
adenocarcinoma (160) 160
adenocarcinoma - surgery (160) 160
docetaxel (156) 156
gemcitabine (156) 156
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1632) 1632
Japanese (1403) 1403
Chinese (21) 21
French (4) 4
Italian (2) 2
Czech (1) 1
German (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINES | OXALIPLATIN | III NONINFERIORITY | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2014, Volume 110, Issue 10, pp. 2506 - 2513
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2018, Volume 13, Issue 8, p. e0202901
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 11/2017, Volume 32, Issue 11, pp. 1839 - 1845
Journal Article
Dalton transactions (Cambridge, England : 2003), ISSN 1477-9226, 07/2014, Volume 43, Issue 25, pp. 9740 - 9753
The diiron unit is commonly found as the active site in enzymes that catalyze important biological transformations. Two μ-(hydr)oxo-diiron(iii) complexes with... 
Protons | Oxidation-Reduction | Magnets - chemistry | Models, Molecular | Crystallography, X-Ray | Oxonic Acid - chemistry | Heme - chemistry | Hydrogen Bonding | Iron Compounds - chemistry | Oxygen - chemistry | Benzoic Acid - chemistry | Electrochemistry | Catalysis
Journal Article
Blood Purification, ISSN 0253-5068, 12/2005, Volume 24, Issue 1, pp. 67 - 70
Journal Article
Journal Article
Molecules, ISSN 1420-3049, 10/2018, Volume 23, Issue 10, p. 2671
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 2010, Volume 52, Issue 4, pp. 550 - 556
Journal Article
Journal Article